CD26 antigen, BIOLOGICAL assay, CLINICAL trials, ENZYME inhibitors, MEDICAL research
Abstract
Researchers from Al-Azhar University in Assiut, Egypt have developed a new method for assessing the drug sitagliptin (STG), which is used to manage type 2 diabetes. The method involves using a dihydropyridine derivative called pentane-2,4-dione to create a fluorescent molecule that can be measured using spectrofluorimetry. The researchers found that this method was simple, effective, and quick, making it a useful tool for quality control and clinical study assays of STG. This research has been peer-reviewed and provides valuable insights for pharmaceutical and biological matrices. [Extracted from the article]
Published
2023
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.